erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Airway Obstruction D000402 13 associated lipids
Tuberculosis D014376 20 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Adenocarcinoma D000230 166 associated lipids
Bacterial Infections D001424 21 associated lipids
Otitis Externa D010032 8 associated lipids
Pain D010146 64 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Stomach Diseases D013272 7 associated lipids
Genital Diseases, Female D005831 7 associated lipids
Alveolitis, Extrinsic Allergic D000542 6 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Skin Neoplasms D012878 12 associated lipids
Pleurisy D010998 20 associated lipids
Inflammation D007249 119 associated lipids
Diabetes Mellitus, Type 1 D003922 56 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Genital Diseases, Male D005832 3 associated lipids
Sexually Transmitted Diseases D012749 4 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Body Weight D001835 333 associated lipids
Edema D004487 152 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Bone Resorption D001862 7 associated lipids
Arthritis D001168 41 associated lipids
Surgical Wound Infection D013530 7 associated lipids
Abscess D000038 13 associated lipids
Hypotension D007022 41 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Heart Failure D006333 36 associated lipids
Osteitis D010000 10 associated lipids
Osteomyelitis D010019 10 associated lipids
Liver Diseases D008107 31 associated lipids
Corneal Diseases D003316 13 associated lipids
Intestinal Obstruction D007415 6 associated lipids
Pancreatitis D010195 10 associated lipids
Hypersensitivity D006967 22 associated lipids
Acne Vulgaris D000152 35 associated lipids
Osteolysis D010014 8 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Igari J and Kano M [Basic study on chemotherapy of urinary tract infection. 3. Effect of urine pH on antibacterial activity of macrolides, lincomycin and clinimycin on Escherichia coli]. 1968 Jpn J Antibiot pmid:4887887
Lange A and Volkening R [Resistance quota of some bacterial species to various antibiotics]. 1968 Med Welt pmid:4888218
Savel'eva TL [Antibiotics in the treatment of actinomycoses]. 1968 Antibiotiki pmid:4878102
Rychlík I and Cerná J Cross resistance of Escherichia coli B. ribosomes to inhibition of the puromycin reaction by erythromycin, spiramycin and chloramphenicol. 1968 Hoppe-Seyler's Z. Physiol. Chem. pmid:4878426
Kiselev RN [Intestinal microflora in mice and its change under the effect of antibiotics]. 1968 Antibiotiki pmid:4879870
Garanin BA [Sensitivity toward antibiotics of Shigella, isolated rom the patients in years 1960-1965, from the data from Hospital of Infectious Diseases]. 1968 Antibiotiki pmid:4880237
Gomez JR and Gomez G Comparative trial of erythromycin and tetracycline in common infections found in general practice. 1968 Br J Clin Pract pmid:4880249
Kaempfer R Ribosomal subunit exchange during protein synthesis. 1968 Proc. Natl. Acad. Sci. U.S.A. pmid:4880603
Nuzzolo L et al. [Research on the antibacterial activity in vitro, and on blood concentrations in man, of an association of erythromycin with sulfadiazine, sulfamerazine and sulfamethazine]. 1968 Clin Ter pmid:4883849
Avian tuberculosis. 1968 Scott Med J pmid:4884700
Anaka K and Teraoka H Effect of erythromycin on polylysine synthesis directed by polyadenylic acid in an Escherichia coli cell-free system. 1968 J. Biochem. pmid:4885037
Bouanchaud DH et al. Elimination by ethidium bromide of antibiotic resistance in enterobacteria and staphylococci. 1968 J. Gen. Microbiol. pmid:4885039
Tanaka K et al. Erythromycin-resistant mutant of Escherichia coli with altered ribosomal protein component. 1968 Science pmid:4886608
Linnane AW et al. The biogenesis of mitochondria. V. Cytoplasmic inheritance of erythromycin resistance in Saccharomyces cerevisiae. 1968 Proc. Natl. Acad. Sci. U.S.A. pmid:5238670
Linnane AW et al. The biogenesis of mitochondria, VI. Biochemical basis of the resistance of Saccharomyces cerevisiae toward antibiotics which specifically inhibit mitochondrial protein synthesis. 1968 Proc. Natl. Acad. Sci. U.S.A. pmid:5240029
Woods R Antibiotic treatment of pyogenic infections of dental origin. 1968 Aust Dent J pmid:5240656
Berthelot et al. [Clinical study and determination of blood and salivary level of erythromycin ethyl-succinate]. 1968 Inf Dent pmid:5245648
Cooper RG et al. An erythromycin-resistant pneumococcus. 1968 Med. J. Aust. pmid:4385911
Lang N et al. On the mechanism of hormone action. VII. Induction by cortisol of a messenger RNA coding for tyrosine-alpha-ketoglutarate transaminase for an in vitro system. 1968 Acta Endocrinol. pmid:4384442
Corse J and Williams RE Antibiotic resistance of coagulase-negative staphylococci and micrococci. 1968 J. Clin. Pathol. pmid:5191722
Petricević I et al. [Hepatitis caused by erythromycin]. 1968 Lijec Vjesn pmid:5195777
Schonell ME et al. Disseminated infection with Mycobacterium avium: I. Clinical features, treatment and pathology. 1968 Tubercle pmid:4969143
Clark J et al. Disseminated infection with Mycobacterium avium: II. Bacteriology and drug susceptibility. 1968 Tubercle pmid:4969144
Saggers BA and Lawson D In vivo penetration of antibiotics into sputum in cystic fibrosis. 1968 Arch. Dis. Child. pmid:4969417
Franco S et al. Erythromycin in childhood pneumonias. 1968 Curr Ther Res Clin Exp pmid:4969674
Edmond E et al. Avian tuberculosis. 1968 Scott Med J pmid:5751239
Pulverer G [Studies with lysotaphin. II. Lysostaphin sensitivity of 230 strains of Staph. aureus of animal origin]. 1968 Z Med Mikrobiol Immunol pmid:5751715
Mikuni M et al. [Present status of chemotherapy in ophthalmology, with special reference to recent antibiotics]. 1968 Ganka pmid:5752591
Willcox RR Erythromycin in the treatment of non-gonococcal urethritis. 1968 Br J Vener Dis pmid:5761021
Schultz EJ Evaluation of erythromycin in the treatment of infectious bovine mastitis. 1968 J. Am. Vet. Med. Assoc. pmid:5761379
Gabraschanski P [Gallimycin for therapy and prophylaxis of some diseases or the rock partridge in Bulgaria]. 1968 Dtsch Tierarztl Wochenschr pmid:5693286
Monnier J and Bourse R [Antibacterial activity in vitro of a new rifamycin: rifamide]. 1968 Pathol Biol pmid:4972879
Poralla K and Zähner H [Metabolic products of microorganisms. 62. The inhibition of the incorporation of threonine in sRNA in cell-free systems and of the synthesis of proteins and nucleic acids in the cell by the antibiotic borrelidin]. 1968 Arch Mikrobiol pmid:4974079
Ozawa A [On the sensitivity of various gram-negative bacilli to demethylchlortetracycline (Ledermycin)]. 1968 Jpn J Antibiot pmid:4974355
Malski M [Effect of penicillin, aureomycin, chloramphenicol and erythromycin on tubercle bacilli]. 1968 Gruzlica pmid:4974660
Benzi G et al. [Effect of erythromycin, various tetracyclines and rifomycin SV, on extrahepatic bile ducts]. 1968 Boll Chim Farm pmid:4976427
Wakuta T Mutual relationship of Candida and Lactobacillus in mixed culture. 1968 Bull. Tokyo Med. Dent. Univ. pmid:4976549
Vakulenko NA [Unification of the method for determination of biological activity of antibiotics by means of single test culture]. 1968 Antibiotiki pmid:4976625
Rotheim MB and Ravin AW Inactivation and reversion of multisite streptomycin resistance mutations of Pneumococcus. 1968 Mol. Gen. Genet. pmid:5713396
Onodera T et al. Effect of fluid and antibiotic administration on experimental fecal peritonitis. 1968 Tohoku J. Exp. Med. pmid:5715596
Smith LT et al. Reproductive performance of pheasant breeder hens. 1968 Poult. Sci. pmid:5716660
Velluti G and Grifa P [In vitro activity of erythromycin on various mycobacterium strains]. 1968 G Mal Infett Parassit pmid:4976935
Levy A et al. [Study "in vitro" and "in vivo" using erythromycin stearate in the therapy of respiratory and cutaneous infections]. 1968 Rev Bras Med pmid:5717048
Acocella G et al. Biliary excretion of antibiotics in man. 1968 Gut pmid:5717103
Voors AW and Stewart GT Statistical analysis of staphylococcal infection in hospital patients in relation to use of antibiotics and other factors. 1968 J Hyg (Lond) pmid:5250128
Kanno M et al. [Study on progressive muscular dystrophy. 1. Influence of the various drugs on serum enzyme activity and the degree of disability]. 1968 Iryo pmid:5717702
Schlecht S and Westphal O [Antibiotic sensitivity in S- and R-forms of Salmonella minnesota]. 1968 Naturwissenschaften pmid:5725584
Akzhigitov GH et al. [The treatment of traumatic pancreatitis with antibiotics and their secretion with pancreatic juice]. 1968 Vestn. Khir. Im. I. I. Grek. pmid:5729234
Sugiyama H [Experimental studies on control of dental caries. 2. Erythromycin and oral microbial flora]. 1968 Aichi Gakuin Daigaku Shigakkai Shi pmid:5261349
Mozziconacci P and Attal C [Treatment of rheumatic cardiopathies]. 1968 Sem Hop pmid:4307324
Cairella M and Marasà G [The chemoantibiotics in infections of the bile ducts]. 1968 Clin Ter pmid:4982819
da Silva WB et al. [Use of a chloramphenicol-erythromycin combination in the treatment of lung diseases in children]. 1968 Hospital (Rio J) pmid:5308493
Puito L [Antibiotic therapy in infancy]. 1968 Pediatria (Napoli) pmid:4312284
Jones PH and Rowley EK Chemical modifications of erythromycin antibiotics. I. 3'-de(dimethylamino)erythromycin A and B. 1968 J. Org. Chem. pmid:5636610
Thomas DY and Wilkie D Recombination of mitochondrial drug-resistance factors in Saccharomyces cerevisiae. 1968 Biochem. Biophys. Res. Commun. pmid:5637042
Petit JF et al. Biosynthesis of the peptidoglycan of bacterial cell walls. VII. Incorporation of serine and glycine into interpeptide bridges in Staphylococcus epidermidis. 1968 J. Biol. Chem. pmid:5638592
Hanley JE et al. An evaluation and comparison of spectinomycin and spectinomycin-erythromycin combinations for infectious coryza. 1968 Avian Dis. pmid:5643698
Breitfellner G et al. [Staphylococci in the Vienna area. Epidemiology, antibiotic sensitivity and therapeutic aspects]. 1968 Wien. Klin. Wochenschr. pmid:5188335
Sotaniemi E and Huhti E Bronchial asthma and toxic hepatitis. 1968 Ann Allergy pmid:5644356
Parisi JT and Suling WJ Antibiotic resistance of glycine-resistant variants of Staphylococcus aureus. 1968 Can. J. Microbiol. pmid:5188340
Desmyter J Lincomycin resistance of erythromycin-resistant cocci. 1968 N. Engl. J. Med. pmid:5644571
Bulger RJ and Sherris JC Decreased incidence of antibiotic resistance among Staphylococcus aureus. A study in a university hospital over a 9-year period. 1968 Ann. Intern. Med. pmid:5188901
Popovici GG et al. The influence of some antibiotics on glucose-6-P-NADP-oxido-reductase (G6PDH) activity. 1968 Arch Int Pharmacodyn Ther pmid:5646007
Sprunt K et al. Penicillin resistant alpha Streptococci in pharynx of patients given oral penicillin. 1968 Pediatrics pmid:5188913
Novick RP and Roth C Plasmid-linked resistance to inorganic salts in Staphylococcus aureus. 1968 J. Bacteriol. pmid:5646621
Alberti RL Teeth discoloration and enamel hypoplasia caused by erythromycin. 1968 S. Afr. Med. J. pmid:5647172
Doyle WM et al. Pulmonary disease caused by Mycobacterium xenopei. 1968 Am. Rev. Respir. Dis. pmid:5647216
Thomas DY and Wilkie D Inhibition of mitochondrial synthesis in yeast by erythromycin: cytoplasmic and nuclear factors controlling resistance. 1968 Genet. Res. pmid:5648765
Osman HG et al. Factors influencing the biosynthesis of erythromycin by Streptomyces erythreus. 1968 Z. Allg. Mikrobiol. pmid:4916831
Simon C and Latz E [Antibiotic therapy of staphylococcal infections. The influence of chloramphenicol and erythromycin on the bactericidal effect of penicillin G and methicillin in vitro]. 1968 Med Welt pmid:5663162
Narasimhan MJ and Ganla VG The broad-spectrum and the macrolide antibiotics and the ciliary barrier. 1968 Hindustan Antibiot Bull pmid:5663533
Bertrand JL [Combination of propionyl-erythromycin, tetracycline and lysozyme in anti-infective therapy in adults and children]. 1968 Lyon Med pmid:5664960
Bülow P A new epidemic phage type of Staphylococcus aureus. 3. Occurrence and spread of "type 6557", with special reference to the consumption of some antibiotics. 1968 Acta Pathol Microbiol Scand pmid:4244485
Lamb AJ et al. The biogenesis of mitochondria. 4. The differentiation of mitochondrial and cytoplasmic protein synthesizing systems in vitro by antibiotics. 1968 Biochim. Biophys. Acta pmid:5667290
Macfarlane JA et al. Spiramycin the the prevention of postoperative staphylococcal infection. 1968 Lancet pmid:4169066
Pacha RE Characteristics of Cytophaga psychrophila (Borg) isolated during outbreaks of bacterial cold-water disease. 1968 Appl Microbiol pmid:4169926
Chisholm WS Erythromycin-sulfas in pediatric practice: efficacy and patient acceptance. 1968 Ariz Med pmid:5674274
Johnstone FR and Cockcroft WH Clostridium welchii resistance to tetracycline. 1968 Lancet pmid:4170649
Higashide E et al. Enduracidin, a new antibiotic. I. Streptomyces fungicidicus No. B5477, an enduracidin producing organism. 1968 J. Antibiot. pmid:5674368
Hadida E et al. [Dissecting cellulitis of the scalp]. 1968 Bull Soc Fr Dermatol Syphiligr pmid:5677894
Chernomordik AB [Antibiotic lincomycin]. 1968 Antibiotiki pmid:4894135
VaÄ­sberg GE and Meshkov MI [Treatment of patients with microbial eczema by prodigiozan in combination with antibiotics]. 1968 Antibiotiki pmid:5678111
Gause GG and Grünberger D Translational characteristics of ribosomes and coding properties of transfer RNA in the mutant of bacterium paracoli with the increased GC content of DNA. 1968 Biochim. Biophys. Acta pmid:5680608
Arret B and Eckert J New developments in antibiotic interference thresholds of microbial assays. 1968 J Pharm Sci pmid:4297949
Wayland LG and Weiss PJ Identification of antibiotics in sensitivity disks. 1968 J Pharm Sci pmid:4173079
Swart H [A case of Gaffkya sepsis]. 1968 Ned Tijdschr Geneeskd pmid:5680825
Rouquès L [Scarlet fever in 1968]. 1968 Presse Med pmid:5305215
Winningham DG et al. Diffusion of antibiotics from plasma into prostatic fluid. 1968 Nature pmid:4298194
Peterson JM and Guild WR Fractionated strands of bacterial deoxyribonucleic acid. 3. Transformation efficiencies and rates of phenotypic expression. 1968 J. Bacteriol. pmid:4387147
Grady JE Recent developments in lincomycin research. 1968 Int Z Klin Pharmakol Ther Toxikol pmid:4388454
Tereshin IM and Belousova II [Effect of some antibiotics on the transfer of the resistance to tetracycline and chloramphenicol by means of the episome factor (Rtf)]. 1968 Antibiotiki pmid:4298603
Rodovalho SF [Tolerance and efficiency of erythromycin suppositories used in respiratory infections in ambulatory pediatric practice]. 1968 Hospital (Rio J) pmid:5306207
Nakazawa S et al. [Experimental chemotherapy of Proteus vulgaris infection]. 1968 Jpn J Antibiot pmid:4299624
Hirasawa K [Studies on renin-angiotensin system. I. Angiotensinase activities in hepatic disorders]. 1968 Jpn. Circ. J. pmid:4299837
Alterio DL [Clinico-parasitological evaluation of an anti-ameba therapeutic activity of a new non-absorbable erythromycin stearate preparation]. 1968 Hospital (Rio J) pmid:5307504
Ganança MM [Use of erythromycin suppositories in the treatment of otorhinolaryngologic infections in children]. 1968 Hospital (Rio J) pmid:5307873
Barnes RW et al. Studies of sterility of calf venous blood. 1968 Surgery pmid:4300855
Ruczaj Z Sensitivity of microorganisms to antibiotics produced by them. 1968 Arch. Immunol. Ther. Exp. (Warsz.) pmid:4302938
Siegenthaler W et al. [New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol]. 1968 Antibiot Chemother pmid:4302993
Minkova GL [On the sensitivity of microflora of burn wounds to antibiotics]. 1968 Antibiotiki pmid:4305269